Colin Keeler is Head of Business Development at Kiva Confections, one of the world’s largest and most popular cannabis edibles brands. In his role, Colin is responsible for leading all commercial aspects of Kiva’s rapid growth across non-California markets. Prior to joining Kiva, Colin worked at atai Life Sciences, a NASDAQ-listed biopharmaceutical company focused on psychedelic mental health therapies, as an early employee responsible for business operations, fundraising/investor relations, and venture management. His experience in the cannabis industry includes founding Cannablurbs, a cannabis business and strategy newsletter and consulting company, and investing at Salveo Capital. Earlier in his career, Colin worked in various roles across technology, healthcare investing, and investment banking. Colin holds a BBA from the University of Notre Dame and an MBA from The Wharton School at the University of Pennsylvania.